Pemetrexed-induced acute kidney failure following irreversible renal damage: Two case reports and literature review

Journal of Nephropathology

Volumn 6, Issue 2, 2017, Pages 43-48

  Zattera, Tito ^a   Londrino, Francesco ^b   Trezzi, Matteo ^a   Palumbo, Roberto ^b   Granata, Antonio ^c   Tatangelo, Paola ^b   Corbani, Valentina ^a   Falqui, Valeria ^a   Chiappini, Nadia ^a   Mathiasen, Lisa ^d   Cavallini, Marco ^e   Rolla, Davide ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

^c Ospedale S Giovanni di Dio   (Italy)

^d Estor SpA   (Italy)

^e Ospedale di Dolo   (Italy)

Author keywords

Acute kidney injury; Nephrotoxicity; Pemetrexed

Indexed keywords

CARBOPLATIN; CISPLATIN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; GEMCITABINE; PACLITAXEL; PEMETREXED;

ACUTE KIDNEY FAILURE; ADULT; BONE MARROW SUPPRESSION; BONE METASTASIS; CASE REPORT; CELL INFILTRATION; CELL VACUOLE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERKALEMIA; HYPOVOLEMIA; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; LUNG ADENOCARCINOMA; LUNG EDEMA; LUNG LOBECTOMY; MALE; MEGALOBLASTIC ANEMIA; METABOLIC ACIDOSIS; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROTEINURIA; RESISTIVE INDEX; REVIEW; SWELLING; VOMITING;

EID: 85014843854     PISSN: 22518363     EISSN: 22518819     Source Type: Journal    
DOI: 10.15171/jnp.2017.07     Document Type: Review

References (15)

1. Gonen N, Assaraf YG. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. Drug Resist Updat. 2012;15(4):183-210. doi: 10.1016/j.drup.2012.07.002.
2. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21(14):2636-44. doi: 10.1200/JCO.2003.11.136.
3. Santoro A, O’Brien ME, Stahe RA, Nackaerts K, Baas P, Karthaus M, et al. Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaive patients with malignant pleural mesothelioma: results of the international expanded access program. J Thorac Oncol. 2008;3(7):756-63. doi: 10.1097/JTO.0b013e31817c73d6.
4. Schuette WH, Groschel A, Sebastian M, Andreas S, Muller T, Schneller T, et al. A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer. Clin Lung Cancer. 2013;14(3):215-23. doi: 10.1016/j.cllc.2012.10.001.
5. Socinski MA, Stinchcombe TE, Hayes DN. The evolving role of pemetrexed (Alimta) in lung cancer. Semin Oncol. 2005;32(2 Suppl 2):16-22.
6. Glezerman G, Pietanza MC, Miller V, Seshan SV. Kidney tubular toxicity of maintenance pemetrexed therapy. Am J Kidney Dis. 2011;58(5):817-20. doi: 10.1053/j.ajkd.2011.04.030.
7. Damaraju VL, Hamilton KF, Seth-Smith ML, Cass CE, Sawyer MB. Characterization of binding of folates and antifolates to brush-border membrane vesicles isolated from human kidney. Mol Pharmacol. 2005;67:453-9. doi: 10.1124/mol.104.004978.
8. Vootukuru V, Liew YP, Nally JV Jr. Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer. Med Oncol. 2006;23:419-22. doi: 10.1385/MO:23:3:419.
9. Brandes JC, Grossman SA, Ahmad H. Alteration of pemetrexed excretion in the presence of acute renal failure and effusions: presentation of a case and review of the literature. Cancer Invest. 2006;24:283-7. doi: 10.1080/07357900600629567.
10. Porta JM, Vicente de Vera Floristán C, Inglán PB, Jericó JF. Acute renal failure associated with Pemetrexed (Alimta). Nefrologia. 2009;29:610-1. doi: 10.3265/Nefrologia.2009.29.6.5492.en.full.
11. Castro M. Thymidine rescue: an antidote for pemetrexed-related toxicity in the setting of acute renal failure. J Clin Oncol. 2003;21:4066. doi: 10.1200/JCO.2003.99.092.
12. Michels J, Spano JP, Brocheriou I, Deray G, Khayat D, Izzedine H. Acute tubular necrosis and interstitial nephritis during pemetrexed therapy. Case Rep Oncol. 2009;2:53-6. doi: 10.1159/000208377.
13. Stavroulopoulos A, Nakopoulou L, Xydakis AM, Aresti V, Nikolakopoulou A, Klouvas G. Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed. Ren Fail. 2010;32: 1000-4. doi: 10.3109/0886022X.2010.501930.
14. Chauvet S, Courbebaisse M, Ronco P, Plaisier E. Pemetrexed-induced acute kidney injury leading to chronic kidney disease. Clin Nephrol. 2014;82(12):402-6. doi: 10.5414/CN107921.
15. Rombolà G, Vaira F, Trezzi M, Chiappini N, Falqui V, Londrino F. Pemetrexed induced acute kidney injury in patients with non-small cell lung cancer: reversible and chronic renal damage. J Nephrol. 2015;28(2):187-91. doi: 10.1007/s40620-014-0117-5.